Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HURA TuHURA Biosciences Inc.
- Stocks
- Healthcare
- NASDAQ: HURA
Price (delayed)
$2.7
Market cap
$117.94M
P/E Ratio
6.92
Dividend/share
N/A
EPS
$0.39
Enterprise value
$111.88M
Highlights
The debt has declined by 19% since the previous quarter
TuHURA Biosciences's EPS has soared by 132% from the previous quarter but it has plunged by 99% YoY
TuHURA Biosciences's equity has soared by 66% YoY but it has decreased by 32% from the previous quarter
The quick ratio has plunged by 86% YoY and by 72% from the previous quarter
Key stats
What are the main financial stats of HURA
Market
Valuations
Earnings
Shares outstanding
43.68M
Market cap
$117.94M
Enterprise value
$111.88M
Price to earnings (P/E)
6.92
Price to book (P/B)
11.97
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$22.58M
Net income
-$26.34M
EBIT
-$22.12M
EBITDA
-$22M
Free cash flow
-$17.21M
Per share
Balance sheet
Liquidity
EPS
$0.39
EPS diluted
$0.39
Free cash flow per share
-$0.4
Book value per share
$0.23
Revenue per share
$0
TBVPS
$0.34
Total assets
$14.64M
Total liabilities
$4.78M
Debt
$164,594
Equity
$9.86M
Working capital
$9.54M
Debt to equity
0.02
Current ratio
3
Quick ratio
0.66
Net debt/EBITDA
0.28
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-243%
Return on equity
-365.2%
Return on invested capital
-2,280.6%
Return on capital employed
-224.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HURA stock price
How has the TuHURA Biosciences stock price performed over time
Intraday
10.2%
1 week
1.5%
1 month
-31.12%
1 year
-98.98%
YTD
-33.99%
QTD
-16.41%
Financial performance
How have TuHURA Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.58M
Net income
-$26.34M
Gross margin
N/A
Net margin
N/A
TuHURA Biosciences's operating income has decreased by 28% QoQ but it has increased by 27% YoY
The net income fell by 21% QoQ but it rose by 15% YoY
Price vs fundamentals
How does HURA's price correlate with its fundamentals
Growth
What is TuHURA Biosciences's growth rate over time
Valuation
What is TuHURA Biosciences stock price valuation
P/E
6.92
P/B
11.97
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TuHURA Biosciences's EPS has soared by 132% from the previous quarter but it has plunged by 99% YoY
The P/B is 114% higher than the 5-year quarterly average of 5.6 and 32% higher than the last 4 quarters average of 9.1
TuHURA Biosciences's equity has soared by 66% YoY but it has decreased by 32% from the previous quarter
Efficiency
How efficient is TuHURA Biosciences business performance
HURA's return on equity has surged by 91% year-on-year but it is down by 4.7% since the previous quarter
HURA's ROA has soared by 66% YoY
Dividends
What is HURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HURA.
Financial health
How did TuHURA Biosciences financials performed over time
The total assets has soared by 97% YoY but it has contracted by 27% from the previous quarter
The quick ratio has plunged by 86% YoY and by 72% from the previous quarter
The debt is 98% smaller than the equity
The debt to equity has surged by 100% since the previous quarter
TuHURA Biosciences's equity has soared by 66% YoY but it has decreased by 32% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.